CSBR - Company ID 0000771856
CHAMPIONS ONCOLOGY, INC. (CSBR) reported revenue of $59.42M for fiscal year 2026, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2026 | $59.42M | +4.4% |
| FY 2025 | $56.94M | +13.5% |
| FY 2024 | $50.16M | -6.9% |
| FY 2023 | $53.87M | +9.7% |
| FY 2022 | $49.11M | +19.7% |
| FY 2021 | $41.04M | +27.8% |
| FY 2020 | $32.12M | +1007.7% |
| FY 2019 | $2.90M | -85.7% |
| FY 2018 |
CHAMPIONS ONCOLOGY, INC. (CSBR) reported revenue of $59.42M for fiscal year 2026, as filed in its audited annual report with the SEC.
Between fiscal 2018 and fiscal 2026, CHAMPIONS ONCOLOGY, INC.'s revenue grew from $20.24M to $59.42M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $20.24M |
| - |